Atossa Therapeutics
ATOS
#9205
Rank
โ‚น9.64 B
Marketcap
โ‚น74.70
Share price
-8.82%
Change (1 day)
-21.35%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -โ‚น19.47

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น20.83. In 2024 the company made an earnings per share (EPS) of -โ‚น18.11 an increase over its 2023 EPS that were of -โ‚น21.73.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น19.477.52%
2024-โ‚น18.11-16.67%
2023-โ‚น21.7314.29%
2022-โ‚น19.0116.67%
2021-โ‚น16.30-90.86%
2020-โ‚น178.37-2.96%
2019-โ‚น183.80-63.09%
2018-โ‚น497.99-49.63%
2017-โ‚น988.74-57.87%
2016-โ‚น2,347-74.01%
2015-โ‚น9,029-9.18%
2014-โ‚น9,942-12.86%
2013-โ‚น11,40970.73%
2012-โ‚น6,68234.08%
2011-โ‚น4,984263.47%
2010-โ‚น1,371

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น945.23-4,638.87%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น928.08-4,556.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น782.30-3,856.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น19.01-8.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น79.68 282.61%๐Ÿ‡บ๐Ÿ‡ธ USA